Building Surfaces with Controlled Site-Density of Anchored Human Serum Albumin.

ACS Appl Bio Mater

Laboratory for Molecular Surfaces and Nanotechnology (LAMSUN), Department of Chemical Sciences, University of Catania and CSGI, Viale A. Doria 6, 95125 Catania, Italy.

Published: November 2023

Stable and uniform layers of protein molecules at the surface are important to build passive devices as well as active constructs for smart biointerfaces for a large number of biomedical applications. In this context, a strategy to build-up surfaces able to anchor protein molecules on specific and controlled surface sites has been developed. Human serum albumin (HSA) has been chosen as a model protein due to its important antithrombogenic properties and its features in cell response highly valuable for in vivo devices. Uniform self-assembled monolayers of 2,2':6'2″-terpyridines (SAM), whose sites were further employed to chelate copper and iron ions, forming SAM-Cu(II) and SAM-Fe(II) complexes, have been developed. The effect of two metal cations on the physicochemical features of SAM, including thickness, Young's modulus, and tip-monolayer adhesion factors, has been investigated. Protein adsorption at different concentrations showed that the copper ion-templated surfaces exhibit highly specific mass uptake, kinetic behavior, and recognition and anchoring of HSA molecules owing to the coordination sphere of the different cations. The results pave the way to the development of a more general strategy to obtain ordered and density-tuned arrays of specific metal cations, which in turn would drive the anchoring of precise proteins for different biological functions.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acsabm.3c00647DOI Listing

Publication Analysis

Top Keywords

human serum
8
serum albumin
8
protein molecules
8
metal cations
8
building surfaces
4
surfaces controlled
4
controlled site-density
4
site-density anchored
4
anchored human
4
albumin stable
4

Similar Publications

Background: The impact of protein-bound uremic toxins, specifically indoxyl sulfate (IS) on peritoneal dialysis (PD) complications remains controversial. This study aimed to explore the link between serum total IS (tIS) levels, proinflammatory cytokines in serum and peritoneal dialysis effluent (PDE), and PD technique survival.

Methods: In this prospective cohort study, 84 patients were followed up for three years and analyzed.

View Article and Find Full Text PDF

Objective: The objective of this study was to identify serum complement factor-based biomarkers indicative of clinical efficacy in patients with first-episode schizophrenia (SCZ) following treatment with aripiprazole.

Methods: The retrospective study cohort comprised 40 patients diagnosed with first-episode SCZ (SCZ group) and 40 healthy individuals (control group). Quantitative analyses were conducted on five complement factors, namely complement component 1 (C1), C2, C3, C4, and the 50% hemolytic complement (CH50).

View Article and Find Full Text PDF

Impact of serum lipid on recurrence of uterine fibroids: a single center retrospective study.

BMC Womens Health

December 2024

Department of Gynecology, Ningbo Medical Center Lihuili Hospital, No.1111 Jiangnan Road, Yinzhou District, Ningbo, Zhejiang Province, 315040, China.

Background: We aimed to analyze the correlation between serum lipid levels [total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C)] and recurrence after uterine fibroids (UF) resection, and explore the predictive value of serum lipid levels in determining recurrence after myomectomy.

Methods: In this retrospective cohort study, 323 patients undergoing first myomectomy who came from Li Huili Hospital, Ningbo Medical Center between December 2019 and January 2023 were included. The primary endpoint was the recurrence of UF within 12 months following surgery.

View Article and Find Full Text PDF

Background: Death rates in the intensive care unit (ICU) and paediatric ICU (PICU) are approximately 10.8% and 9.13%, respectively.

View Article and Find Full Text PDF

Introduction: Tuberculosis (TB) is the leading infectious cause of death globally. Despite WHO recommendations for TB preventive therapy (TPT), challenges persist, including incompletion of treatment and adverse drug reactions (ADRs). There is limited data on the 3-month isoniazid and rifapentine (3HP) pharmacokinetics, pharmacogenomics and their relation with ADRs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!